E. ARAS Et Al. , "Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment," INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.247, 2018
ARAS, E. Et Al. 2018. Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1 , 247.
ARAS, E., Tecen, K., Bayraktar-Ekincioglu, A., Demirkan, K., & KILIÇKAP, S., (2018). Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, 247.
ARAS, ELİF Et Al. "Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment," INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, 247, 2018
ARAS, ELİF A. Et Al. "Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment." INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.247, 2018
ARAS, E. Et Al. (2018) . "Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment." INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, p.247.
@article{article, author={ELİF ARAS ATİK Et Al. }, title={Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment}, journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACY}, year=2018, pages={247} }